Pharmaceutical

Coave Therapeutics raises $33m in funding to advance ALIGATER platform

Coave has raised €32m ($33m) in a Series A financing round for advancing its Advanced Vectors-Ligand Conjugates (ALIGATER) platform.

Jan 12, 2025 - 06:00
Coave Therapeutics raises $33m in funding to advance ALIGATER platform
Coave has raised €32m ($33m) in a Series A financing round for advancing its Advanced Vectors-Ligand Conjugates (ALIGATER) platform.
Read the original article

Tags:

Previous Article

Light Horse emerges with $62m and Novartis partnership worth up to $1bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

MSD acquires Harpoon for $680m to strengthen T-cell engager armoury

MSD acquires Harpoon for $680m to strengthen T-cell eng...

Jan 9, 2024

BARDA and Tiba Biotech link to develop ‘flu therapeutics

BARDA and Tiba Biotech link to develop ‘flu therapeutics

Jul 12, 2024

Ro pauses advertising of weight loss drug Wegovy amid shortages

Ro pauses advertising of weight loss drug Wegovy amid s...

Jun 12, 2023